Literature DB >> 30912164

Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression.

Gang Chen1, Yue Gu1, Peng Han2, Zhong Li1, Jin-Lu Zhao1, Mei-Zhuo Gao1.   

Abstract

Evidence, demonstrating long noncoding RNAs (lncRNAs) as critical players in cancer, remains to increase. lncRNA SBF2-AS1 was reported to be involved in several cancers, such as hepatocellular carcinoma. However, the role of SBF2-AS1 in colorectal cancer (CRC) is unknown. We showed lncRNA SBF2-AS1 expression was growing in CRC samples, especially in advanced cases. Accordingly, SBF2-AS1 possesses higher expression in CRC cell lines than in normal cell line. Moreover, SBF2-AS1 high expression indicated a low survival rate. Functionally, SBF2-AS1 knockdown suppressed the proliferation, migration, and invasion of CRC cells. In terms of mechanism, SBF2-AS1 upregulation restrained the activity of miR-619-5p and led to overexpression of HDAC3. Importantly, downregulation of miR-619-5p or HDAC3 overexpression reversed SBF2-AS1-silencing-caused suppression on proliferation and metastasis. Summarily, our findings elucidated a crucial role of SBF2-AS1 as a miR-619-5p sponge, shedding novel light on lncRNA-related prognostics.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  SBF2-AS1; colorectal cancer; invasion; long noncoding RNA; proliferation

Mesh:

Substances:

Year:  2019        PMID: 30912164     DOI: 10.1002/jcp.28509

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer.

Authors:  Xuhong Zhao; Wenhao Weng; Yin Long; Weijie Pan; Zhi Li; Fenyong Sun
Journal:  Hum Cell       Date:  2020-08-10       Impact factor: 4.174

4.  LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.

Authors:  Hao Chen; Lining Wei; Min Luo; Xiaochen Wang; Chaohua Zhu; Huixian Huang; Xu Liu; Heming Lu; Yahua Zhong
Journal:  Cell Biol Toxicol       Date:  2021-07-28       Impact factor: 6.691

5.  The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.

Authors:  Jie Wang; Pingyong Zhong; Hao Hua
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

6.  Long Noncoding RNASBF2-AS1 Promotes Gastric Cancer Progression via Regulating miR-545/EMS1 Axis.

Authors:  Mingyuan He; Li Feng; Lingzhi Qi; Min Rao; Yonggang Zhu
Journal:  Biomed Res Int       Date:  2020-06-12       Impact factor: 3.411

7.  Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.

Authors:  Mingdong Li; Shengrong Long; Jinqu Hu; Zan Wang; Chao Geng; Shaowu Ou
Journal:  Aging (Albany NY)       Date:  2019-11-06       Impact factor: 5.682

8.  Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.

Authors:  Zi Yin; Yu Zhou; Tingting Ma; Sheng Chen; Ning Shi; Yiping Zou; Baohua Hou; Chuanzhao Zhang
Journal:  J Cell Mol Med       Date:  2020-04-16       Impact factor: 5.310

9.  Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis.

Authors:  Ming Wu; Yujie Zhao; Nanxi Peng; Zuo Tao; Bo Chen
Journal:  Invest New Drugs       Date:  2021-01-04       Impact factor: 3.850

10.  Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.

Authors:  Qiang Zhang; Xiao-Jun Liu; Yang Li; Xiao-Wei Ying; Lu Chen
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.